In recent years, many human central nervous systems (CNS) of microfluidic platforms and related disease models in vitro have been built with the continuous development of the microfluidic technology and biological microelectronics mechanical systems technology. Microplatforms have emerged to provide a better approximation of the in vivo scenario with better control of the structure, microenvironment and stimuli. This review summarized the basic technology of microfluidic chips in CNS and the application in CNS diseases. In addition, the research of microfluidic chip in CNS diseases has been also prospected. We also highlight challenges that can be addressed with interdisciplinary efforts to achieve more biomimicry.